凯发k8一触即发
凯发k8一触即发:About Us
凯发k8一触即发:About Sino Biopharm
凯发k8一触即发:Board of Directors
凯发k8一触即发:Senior Management
R&D
R&D Team
凯发k8一触即发:Products
凯发k8一触即发:Product List
凯发k8一触即发:Sustainability
凯发k8一触即发:ESG Governance
凯发k8一触即发:ESG Management Practices
凯发k8一触即发:ESG Reports
凯发k8一触即发:Investors
凯发k8一触即发:Information Disclosure
凯发k8一触即发:Corporate Governance
凯发k8一触即发:Presentation
Investor FAQ
Notices
凯发k8一触即发:News
凯发k8一触即发:Press Releases
凯发k8一触即发:Contact
CN
EN
Investors
Home
>
凯发k8一触即发:Investors
>
Corporate Governance
凯发k8一触即发:
Information Disclosure
凯发k8一触即发:
Corporate Governance
凯发k8一触即发:
Presentation
凯发k8一触即发:
Investor FAQ
凯发k8一触即发:
Notices
Corporate Governance
Procedures for a shareholder to propose a person for election as a director
2021.07.14
1
2
